| Michael R Dillard, MD | |
|
835 E Fairhaven Ave, Burlington, WA 98233-1916 | |
| (360) 755-0641 | |
| (360) 755-1405 |
| Full Name | Michael R Dillard |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 835 E Fairhaven Ave, Burlington, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376522367 | NPI | - | NPPES |
| 1018043 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD00024124 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael R Dillard, MD Po Box 329, 835 East Fairhaven Ave, Burlington, WA 98233-0329 Ph: (360) 755-0641 | Michael R Dillard, MD 835 E Fairhaven Ave, Burlington, WA 98233-1916 Ph: (360) 755-0641 |
News Archive
To the reasons that chemotherapy sometimes does not work, we can now add one more: bacteria. In a study published today in Science, researchers describe findings that certain bacteria can be found inside human pancreatic tumors.
On average, one hundred billion cells in the human body divide over the course of a day. Most of the time the body gets it right but sometimes, problems in cell replication can lead to abnormalities in chromosomes resulting in many types of disorders, from cancer to Down Syndrome.
St. Jude Children's Research Hospital and the University of Florida Proton Therapy Institute have formed a collaboration to provide proton therapy for St. Jude patients. The announcement follows the approval of the first clinical study to evaluate the use of proton therapy for rare brain cancers in children younger than 3 years old.
LifeVantage Corporation, the maker of Protandim®, a clinically proven, science-based therapy for oxidative stress, announced today that a new peer-reviewed study involving Protandim® was published in the scientific journal PLoS ONE. The study, conducted by researchers at Louisiana State University, examined the biochemical mechanisms that underlie the ability of Protandim® to suppress tumors in mice. That ability was previously demonstrated by the authors in a study involving a mouse two-stage model of chemically-induced skin cancer.
Researchers at LSTM, working with colleagues at the Centres for Disease Control and Prevention USA, the Kenya Medical Research Institute, and from the London School of Hygiene and Tropical Medicine, have completed a study to assess the acceptability among pregnant women and health providers in Kenya of a new drug as an alternative to the standard drug used to prevent malaria in pregnancy.
› Verified 6 days ago
Eric R Stark, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Family Medicine, 835 East Fairhaven Avenue, Burlington, WA 98233 Phone: 360-856-7960 Fax: 360-755-1405 | |
Dr. Paul Christopher Creelman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 712 S Burlington Blvd, Burlington, WA 98233 Phone: 360-757-0027 Fax: 360-757-3698 | |
Dr. Michael Joseph Maidan, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 835 E Fairhaven Ave, Burlington, WA 98233 Phone: 360-856-7960 | |
David Douglas Shilling, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 712 S Burlington Blvd, Burlington, WA 98233 Phone: 360-757-0027 Fax: 360-757-3698 | |
Ms. Amy Ellen Navarre Cantrell, PA-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 835 E Fairhaven Ave, Burlington, WA 98233 Phone: 360-755-0641 Fax: 360-755-0765 | |
Dr. Stephen M Aldrich, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1030 E Fairhaven Avenue, Burlington, WA 98233 Phone: 360-755-0311 Fax: 360-755-1272 |